Status:
COMPLETED
Exercise for Breast Cancer Patients (EXCAP)
Lead Sponsor:
University of Rochester
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Fatigue
Eligibility:
FEMALE
21+ years
Phase:
NA
Brief Summary
The purpose of this study is to examine if exercise helps improve cancer-related fatigue. Hypothesis: A structured home-based walking and progressive resistance exercise program will be efficacious i...
Detailed Description
Fatigue is a frequently reported side effect of cancer treatment. Fatigue related to cancer and its treatment is different from fatigue occurring in other situations and its specific causes have not b...
Eligibility Criteria
Inclusion
- Have a primary diagnosis of breast cancer,
- Have a functional capacity rating of 60 or greater on the Karnofsky Performance Scale, when assessed by the oncologist (or physician's designee)
- Be breast cancer survivor(e.g., surgery, radiation therapy, chemotherapy, hormone therapy). Have a life expectancy of \>1 year as determined by the patient's oncologist.
- Have the approval of their treating physician, study physician(or physician's designee) to participate in sub-maximal physiological fitness testing and a low to moderate home-based walking and progressive resistance exercise program.
- Be able to read English.
- Be 21 years of age or older.
- Give informed consent.
Exclusion
- Have bone metastases that preclude participation in an exercise program either due to symptoms such as pain or location of bone metastasis.
- Have physical limitations (i.e. cardiorespiratory, orthopedic, central nervous system) that contraindicate participation in sub-maximal physiological fitness testing, or a low to moderate home-based walking and progressive resistance program, as assessed by the PAR-Q and radiation oncologist (or physician's designee)
- Be identified as in the Active or Maintenance Stage of exercise behavior as assessed by the 1-item Exercise Stages of Change Short Form.
Key Trial Info
Start Date :
May 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 15 2020
Estimated Enrollment :
114 Patients enrolled
Trial Details
Trial ID
NCT00851812
Start Date
May 1 2007
End Date
January 15 2020
Last Update
February 17 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
James P. Wilmot Cancer Center, University of Rochester
Rochester, New York, United States, 14642